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ABSTRACT 19 
BACKGROUND/OBJECTIVES: We aimed to identify trajectories of total and central adiposity from 13 20 
to 21 years, and to investigate how adiposity changes at different phases of adolescence relate to 21 
adulthood cardiovascular risk factors. 22 
SUBJECTS/METHODS: We analysed data from a population-based cohort (EPITeen), Portugal. Body 23 
mass index (BMI) and waist circumference (WC) were measured at 13, 17 and 21y, and sex- and age-24 
specific z-scores were calculated. Adiposity trajectories were identified using mixture growth models 25 
(BMI, n=2901; WC, n=2898). Cardiovascular risk factors were evaluated at 21 years (n=1763): systolic 26 
(SBP) and diastolic blood pressure (DBP), insulin resistance (HOMA-IR), triglycerides and cholesterol. 27 
Association of trajectory, and changes in adiposity z-scores with each cardiovascular risk factor was 28 
estimated by linear regression models.  29 
RESULTS: ‘Normal’, ‘high, declining’ and ‘high, increasing’ trajectories were identified in both sexes. 30 
‘High, increasing’ BMI trajectory was associated with less favourable cardiovascular risk profile at 21 31 
years in both sexes, while ‘high, declining’ presented a more favourable profile, similar to ‘normal’ 32 
trajectory in females. Additionally, BMI increases between 13-17y and 17-21y were associated with 33 
increases in systolic and diastolic blood pressure, and insulin resistance, but more strongly for the 34 
later period. For every SD increase in BMI between 17-21y, mean SBP increased by 1.99 mmHg (95% 35 
CI: 1.01; 2.97) for females and 3.83 mmHg (2.67; 4.98) for males; the respective increase was 1.56 36 
mmHg (0.72; 2.40) and 2.80 mmHg (1.97; 3.64) for DBP and 0.27 (0.21; 0.32) and 0.30 (0.24; 0.36) for 37 
HOMA-IR (log transformed). Similar results were found for WC. 38 
CONCLUSIONS: Increases in adiposity, particularly from late adolescence-to-young adulthood, were 39 
associated with unfavourable cardiovascular profile in early adulthood. A benefit on the 40 
cardiovascular risk profile for participants in the declining adiposity trajectory was observed.  41 
 42 
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INTRODUCTION 44 
The prevalence of obesity has risen rapidly in the recent decades in most western populations .1 High 45 
adiposity is one of main determinants of cardiovascular disease and its role as a cardiovascular risk 46 
factor starts early in life. It has also been implicated in the development of other cardiovascular risk 47 
factors.2 Therefore, the study of how changes in adiposity across the life span i nfluence the 48 
unfavourable progression of the cardiovascular risk factors is important to understand their impact 49 
on the disease development. 50 
The study of growth trajectories in pediatric age is recognized to be of great relevance for 51 
surveillance, etiology and clinical practice,3 being useful for the identification of critical windows for 52 
intervention. A systematic review has shown a moderate tracking of childhood overweight status 53 
into adulthood.4 There is also evidence indicating substantial variations in individual growth 54 
trajectories.5-7 Some studies identified distinct groups of trajectories over the life course, which might 55 
impact differently on the risk of disease.5, 8-11 56 
While growth characteristics from birth to adolescence and its later association with cardiovascular 57 
risk factors are well documented,8, 9, 11, 12 the impact of changes in adiposity from adolescence to 58 
young adulthood is less well described. Yet this period is recognized as critical for weight gain13, 14 and 59 
subject to important biological changes (e.g. puberty).15 60 
Research to estimate the relative contribution of fatness and fat gain at different life stages on adult 61 
cardiovascular risk factors tends to focus mainly on increases in adiposity in childhood16, 17 and 62 
adulthood.18 Some studies have reported that changes in BMI early in life were of greater relevance 63 
for future atherosclerosis19 or metabolic disturbances.20, 21 Also, changes in weight or BMI during 64 
adolescence or later in life are strongly associated to adult blood pressure and metabolic 65 
abnormalities.22-24 However, the periods assessed were different which may limit comparisons 66 
between studies, and limited evidence is available for the changes in other adiposity measures. 67 
Therefore, this study aims: i) to identify distinct trajectories of total and central adiposity from 68 
adolescence (13 years) to early adulthood (21 years); ii) to investigate how adiposity changes at 69 
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particular age periods (13 to 17, or 17 to 21 years) are associated with cardiovascular risk factors at 70 
early adulthood.  71 
 72 
 73 
SUBJECTS AND METHODS 74 
Study sample 75 
We used information from the Epidemiological Health Investigation of Teenagers (EPITeen) study, a 76 
population-based cohort that recruited 13-year-old adolescents born in 1990 and enrolled at schools 77 
of Porto, Portugal, during 2003-2004.25 A second (2007-2008) and a third (2011-2013) evaluations 78 
took place when participants were on average 17 and 21 years.  79 
Our study complies with the Declaration of Helsinki and the Ethic Committee of Hospital S. João and 80 
the Ethics Committee of the Institute of Public Health from the University of Porto approved the 81 
research protocol. Written informed consent was obtained from parents and adolescents in the first 82 
and second study waves, and from participants in the third study wave.  83 
At the recruitment, 2159 eligible adolescents agreed to participate (77.5% participation). In the 84 
second wave, we re-evaluated 1716 participants (79.5%), and a further 783 adolescents who moved 85 
to the schools in Porto joined the cohort. In the third study wave, 1764 participants (60.0%) were 86 
reevaluated.  87 
 88 
Measures 89 
Anthropometrics 90 
At the study site, weight and height were measured with the subject in light indoor clothes and no 91 
shoes, according to standardized procedures. Waist circumference (to the nearest 0.1 cm) was 92 
measured midway between the lower limit of the rib cage and the iliac crest, at the end of gentle 93 
expiration, with a flexible and non-distensible tape.  94 
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BMI and WC z-scores were calculated by sex and age for each study wave, using the mean and 95 
standard deviation of the study sample. 96 
 97 
Cardiovascular risk factors 98 
For this analysis we considered cardiovascular risk factors assessed at 21 years.  99 
An overnight fast intravenous blood sample was taken from an antecubital vein. Glucose, 100 
triglycerides, total cholesterol and high-density lipoprotein cholesterol (HDL) were measured using 101 
conventional methods with an Olympus AU5400® automated clinical chemistry analyzer (Beckman-102 
Coulter®). Insulin was measured by electro chemiluminescent immunoassay using a Cobas® e411 103 
automated analyzer (Roche®). All determinations took place in the Department of Clinical Pathology, 104 
Centro Hospitalar São João, Porto, Portugal.  105 
Low-density lipoprotein cholesterol (LDL-C) was calculated according to the Friedewald equation.26 106 
Insulin resistance was assessed by the homeostatic model assessment (HOMA-IR) method: HOMA-107 
IR= insulin (μU/ml) * glucose (mg/dl) /405.27  108 
Blood pressure was measured according to the guidelines from the American and International 109 
Societies of Hypertension,28 using the oscillometric method (OMRON Blood Pressure Monitor, M6 110 
Comfort). After 10 minutes of rest, two blood pressure measurements were taken, separately by at 111 
least five minutes. A third measure was taken when the difference between the first two was higher 112 
than 5 mmHg. The average of the two closest measurements was used in this analysis. 113 
 114 
Covariates 115 
Perinatal information was obtained at the baseline evaluation of the cohort using questionnaires 116 
administered to the mothers. When available, birth weight was extracted from child health book 117 
records (n=716); otherwise was based on mother’s report. Maternal smoking was classified as: non-118 
smoker; smoker, but not during pregnancy; smoker during pregnancy.   119 
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Parental educational level was defined according to the parent with the highest education level. 120 
Parental occupational position was categorized as “high” (professional and managerial occupations), 121 
“medium” (non-manual and manual skilled occupations) and “low” (semi -skilled and unskilled 122 
occupations). Parental BMI was calculated using self-reported weight and height, and converted to 123 
standard deviation (SD) scores separately for mother, father, and in each study wave. Parental BMI 124 
was defined using BMI z-score from the mother in study wave I, and if not available data from wave II 125 
(24.1%); or when mother’s BMI was missing in both waves, from the father (2.9%).  126 
Family history of diabetes, dyslipidemia and hypertension was asked separately to the mother and 127 
the father, and for each of the diseases classified as: positive, when at least one of the adolescent's 128 
parents had the diagnosis; negative, when both parents reported no diagnosis; or non-classifiable, 129 
when the available information showed no diagnosis for one of the parents, but missing regarding 130 
the other. The participant’s practice of sports was defined as any planned, regular exercise, 131 
regardless of intensity, and excluding obligatory curricular activities. 132 
 133 
Statistical analysis 134 
In order to identify trajectories of BMI and of WC from adolescence into adulthood (aim 1), we 135 
applied mixture growth models, using the PROC TRAJ procedure in SAS (v9.3, SAS Institute Inc., Cary, 136 
NC).29 The models were stratified by sex, and included a random intercept, a random linear and a 137 
quadratic age term. We tested models up to six trajectory groups, and the final number of 138 
trajectories was chosen based on the lowest Bayesian Information Criteria, and also by the 139 
interpretability of the results. For each individual, the mixture growth model generated the 140 
probability of belonging to each trajectory. Individuals were classified in the trajectory to which they 141 
had the highest probability of belonging.  142 
Analysis of the growth trajectories was based on participants with adiposity measures at one or more 143 
ages (n=2901 for BMI; n=2898 for WC).  144 
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To investigate the association of adiposity levels and their changes at different ages with 145 
cardiovascular risk factors in early adulthood (aim 2), we used sex-specific SD scores of BMI and WC 146 
at each age so their associations with CV risk factors can be compared across ages. A logarithmic 147 
transformation was applied to triglycerides and HOMA-IR, since these variables were skewed.  148 
First, we examined the simple associations of CV risk factors at 21 years with adiposity measures at 149 
each age separately. The regression coefficient represents the change in CV risk factor for a SD 150 
increase in the adiposity measure.  151 
Second, the associations of changes in each adiposity measure (i.e. a change in the relative position 152 
in the distribution) between two ages (13 to 17, and 17 to 21 years), with adult CV risk factors were 153 
examined. Each model was conditioned on the adiposity measure at the previous age. For example, 154 
in order to estimate the change in BMI z-score between 13 and 17 years of age on SBP at 21 years, 155 
we applied the regression model: SBP21 = a + b BMI13 + c BMI17 which can be rewritten as SBP21 = 156 
a + (b + c) BMI13 + c (BMI17 – BMI13). The coefficient c can be interpreted as the estimated change 157 
in SBP associated with a SD increase in BMI between 13 and 17 years, given the BMI at 13 years.  158 
All models were stratified by sex and further adjusted for birth weight, mother’s smoking during 159 
pregnancy, parental education, household occupational position, family history of disease, parental 160 
BMI z-score, and participant’s practice of sports. Regarding practice of sports, for associations with 161 
changes in adiposity between 13-17y we used sports at 13y; for changes between 17-21y, sports at 162 
17y. 163 
We applied multiple imputation to the total cohort in order to use the maximum information 164 
available. The imputation model included factors predicting non-response (i.e. sex, 165 
maternal/paternal education and occupation), adiposity measures at all ages, CV risk factors at 21y 166 
and all covariates in the analysis models. We created 30 imputed datasets assuming missing was at 167 
random given observed values of other variables. The regression models and multiple imputation by 168 
chained equations were conducted using SPSS (IBM Corp. Released 2013. IBM SPSS Statistics for 169 
Windows, Version 22.0. Armonk, NY: IBM Corp.). In the regression models we used imputed 170 
8 
 
covariates and adiposity measures, but not imputed outcomes, i.e. we restricted our analysis to 171 
individuals with observed CV risk factors (1763 participants with valid information for at least one 172 
cardiovascular risk factor at 21y). Parameters estimated were combined to obtain overall estimates 173 
using Rubin’s rule.  174 
 175 
 176 
RESULTS 177 
Descriptive data on BMI and WC at each study wave and cardiovascular risk factors at 21 years is 178 
presented in Table 1.  179 
 180 
Trajectories of BMI/WC from adolescence into adulthood 181 
Three trajectory groups of BMI were identified for each sex (Figure 1): ‘normal’ (78.7% in females; 182 
80.4% in males); ‘high, increasing’ (17.0% and 6.4%); and ‘high, declining’ (4.2% and 13.1%). ‘Normal’ 183 
trajectory presented the lowest mean BMI values and low prevalence of overweight at any of the 184 
three study-waves (Supplementary Table S1). At 13 years, subjects in trajectory ‘high, increasing’ 185 
presented intermediate mean values of BMI, however they increased more rapidly with age, and 186 
were the highest at 21 years (29.3% in females; 65.2% in males), compared to the other trajectories. 187 
Trajectory ‘high, declining’ presented the highest mean values of BMI at 13 years, but they decreased 188 
with age, being the prevalence of obesity at 21 years 7.5% and 11.2% for females and males, 189 
respectively (Supplementary Table S1).  190 
For waist circumference, 3 trajectories were also identified (Figure 2) and they were graphically and 191 
in prevalence similar to those identified for BMI. The agreement between the trajectories identified 192 
based on BMI and on WC was strong (observed agreement of 88.0% and 91.4%; kappa=0.657 and 193 
0.745, respectively for females and males). ‘Normal’ WC trajectory was found in around 80% of the 194 
subjects in both sexes; ‘high, increasing’ in 17.9% of females and 8.4% of males; and trajectory ‘high, 195 
declining’ in 2.0% and 11.6% of females and males, respectively (Supplementary Table S2).  196 
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Table 2 relates cardiovascular risk factors at 21 years to the probability of belonging to each 197 
trajectory. Considering the ‘normal’ trajectory as the reference group, belonging to the ‘high, 198 
increasing’ trajectory was associated with higher SBP, HOMA-IR, triglycerides and LDL, and decreased 199 
HDL at 21y in both sexes, but stronger in males, except for HDL. For ‘high, declining’ trajectory, in 200 
females there were no statistically significant differences in cardiovascular risk factors, compared to 201 
the ‘normal’ trajectory, except for HDL. In males, higher probability of belonging to the ‘high, 202 
declining’ trajectory was associated with higher mean SBP, DBP, HOMA-IR and triglycerides, and 203 
lower HDL at 21 years, but the magnitude was lower than for subjects belonging to the ‘high, 204 
increasing’ trajectory.  205 
The associations for WC (Table 2) were in general similar to those for BMI, but weaker.  206 
 207 
Associations between changes in BMI/WC and CV risk factors 208 
Adjusted models using multiple imputation showed that BMI z-score at each age (13, 17 or 21y) was 209 
positively associated with SBP, DBP, HOMA-IR, triglycerides and LDL, and inversely associated with 210 
HDL, in both sexes, and appeared to be stronger in males (Table 3). Associations generally 211 
strengthened with increasing age. Results for WC z-score were similar, but associations were slightly 212 
weaker (Table 3).  213 
Changes in BMI z-score from 13 to 17y and from 17 to 21y were positively associated with SBP, DBP 214 
and HOMA in both sexes (Table 4). For example, in females for every SD increase in BMI between 13-215 
17y, SBP increased on average by 1.79 mmHg (95% CI 0.48; 3.10), while for every SD increase 216 
between 17-21y, SBP increased on average by 1.99 mmHg (1.01; 2.97); for males associations were 217 
stronger: 2.03 mmHg (0.47; 3.59) for BMI changes for 13-17y, and 3.83 mmHg (2.67; 4.98) for 17-21y. 218 
For triglycerides and LDL, the association was stronger for 17-21y than 13-17y. For HDL an inverse 219 
association was found for the period 13-17y in both sexes, and for 17-21y only in males.  220 
Similar results were found for WC z-score (Table 4): positive associations between increases in WC 221 
and SBP, DBP, HOMA-IR, triglycerides and LDL and negative associations with HDL. 222 
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Either for BMI or WC, regression coefficients were in general stronger in males and for the period 17 223 
to 21 years.    224 
Analyses were repeated using complete cases and as conclusions were mostly unaltered, those 225 
results are presented only in supplementary information (Tables S3 and S4).  226 
 227 
DISCUSSION 228 
Main findings 229 
Using our longitudinal population-based study we identified three trajectories of total and central 230 
adiposity from adolescence to adulthood. While the majority (>75%) of individuals were in the 231 
normal trajectory group, the ‘high, increasing’ trajectory  (more frequently females) had a high 232 
BMI/WC in adolescence and gained BMI/WC more rapidly thereafter, presenting the highest 233 
prevalence of obesity and the worst profile of cardiovascular risk factors at 21 years of age, 234 
particularly in males. A small group (more frequently males) had a high BMI/WC in early adolescence 235 
but it declined from adolescence to early adulthood. Among ‘high, declining’ group, in females the 236 
CV risk factors at 21 years did not differ from normal group, while for males, although worse than 237 
those in the normal group, CV risk factors were more favorable than those in the ‘high, increasing’. In 238 
addition to the identification of trajectories, we also found that adiposity changes from 13 to 21 239 
years were associated with unfavorable values of the cardiovascular risk factors evaluated, and 240 
excessive increases between 17 and 21 years of age (moving up in relative position for BMI in the 241 
population) were particularly influential. These results were similar using either BMI or WC.  242 
 243 
Strengths and limitations 244 
Major strengths of this study include the use of both BMI and WC and applying innovative modelling 245 
techniques for the identification of trajectories, allowing the study of the effect of cumulative 246 
exposure to adiposity on CV risk factors, and not only the effect of the adiposity in a specific age. 247 
Additionally, in a period under characterized – transition from adolescence to adulthood, our study 248 
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adds information on the specific effect of adiposity changes at different ages. We used repeated 249 
measurements of adiposity objectively measured under standardized procedures, as well as 250 
repeated measurements of many confounders, from a population-based cohort, enabling the 251 
generalizability of the results.   252 
Nonetheless, potential limitations of the study exist. Losses to follow-up and item non-response led 253 
to missing data. We conducted analyses using multiple imputation for BMI, WC and covariates 254 
including the main predictors of missing data, which would have reduced selection bias. However, 255 
our final models we fitted only to participants with measured outcomes in the third study wave. 256 
Attrition in the third wave was higher among participants with lower parental education, and among 257 
those obese at the recruitment age. The underrepresentation of obese participants may have led to 258 
an underestimation of the associations reported in our study.   259 
 260 
Interpretation of findings 261 
Information on growth trajectories in the period from adolescence to adulthood is limited. To our 262 
knowledge, five studies have identified BMI trajectories in this age period using similar 263 
methodology11, 30-33 and found three to four distinct trajectories, with some groups being similar to 264 
the trajectories ‘normal’ and ‘high, increasing’ identified in our study. A declining trajectory was only 265 
identified in two of these studies.11, 32 Ziyab and colleagues,11 using data from infancy to 18 years, 266 
identified an ‘early transient overweight’ trajectory. However, this trajectory was characterized by a 267 
decline in BMI z-score from 1 to 10 years of age, and a stabilization from 10 to 18 years, while the 268 
declining trajectory in our study presented declining values of BMI more pronounced from 17 to 21 269 
years of age, than from 13 to 17 years. In Canada’s National Longitudinal Survey of Children and 270 
Youth32 a decreasing trajectory was also identified from age 1 to 20 years and the decrease in BMI 271 
values was more evident in females, as we also found in our study, although it occurred at earlier 272 
ages in their study – from early to mid-adolescence. The small sample size of the group ‘high, 273 
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declining’ identified in our sample, particularly in females, limited our ability to explore in depth the 274 
characteristics of this group.  275 
‘High, increasing’ trajectory presented the worst levels of cardiovascular risk factors at 21 years of 276 
age, while the levels in the ‘high, declining’ trajectory were closer to those in the ‘normal’ group. This 277 
finding is also in accordance to other study that found higher systolic and diastolic blood pressure at 278 
18 years in the delayed overweight trajectory in comparison to the ‘normal’ trajectory, but still 279 
smaller than the values found for the early persistent obesity trajectory.11 Regarding studies in other 280 
age ranges, in the Raine Study,7 those in increasing trajectories from birth to 14 years presented the 281 
highest insulin resistance levels at 14 years, while the outcome in those from declining trajectories 282 
was similar to those in the reference trajectory ( ‘Optimal growth’). Girls in the ‘upward percentile 283 
crossing’ trajectory from 5 to 15 years had highest metabolic risk factors at 15 years, while the 284 
‘delayed downward percentile crossing’ presented similar levels in comparison to the ‘50th percentile 285 
tracking’.9 These results and those from our study suggest that excessive gains in adiposity during the 286 
pediatric ages are associated with adverse cardiovascular risk factors, partly because it is likely to 287 
result in high current BMI. This is supported by the sex-differences in the association between ‘high, 288 
declining’ trajectory and the cardiovascular risk factors in our study. In females there was a marked 289 
decrease in BMI between 13 to 21 years in this trajectory, but the final BMI mean value was close r to 290 
the mean BMI value in the ‘normal’ trajectory and this resulted in no statisti cally significant 291 
differences in the outcomes between these two trajectories. In males, there was a small decline in 292 
BMI mean values, but the difference in BMI values at 21 years in comparison to the ‘normal’ 293 
trajectory was higher than in females, resulting in increased values of cardiovascular risk factors at 21 294 
years, although of lower magnitude in comparison to the ‘high, increasing’ group . 295 
To our knowledge, this is the first study addressing waist circumference trajectories in the period 296 
from adolescence to adulthood. Trajectories of WC were similar to the BMI trajectories, and 297 
associations of WC trajectories with cardiovascular risk factors at 21 years were of the same 298 
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magnitude to those found for BMI trajectories. Although WC is described as a measure of central or 299 
abdominal adiposity, it is highly correlated to BMI (correlations around 0.8 in females and 0.9 in 300 
males at each age, in our study). Other studies have found that BMI and WC perform similarly in the 301 
association with cardiovascular risk factors.34-36 302 
We found that changes in adiposity, both from 13 to 17 years and from 17 to 21 years, were 303 
associated to unfavorable cardiovascular risk parameters at 21 years, but the magnitude was 304 
stronger for the later period. These results suggest that changes in adiposity in these specific ages (17 305 
to 21 years) are more relevant for CV risk factors. During early and mid-adolescence the effect of 306 
adiposity changes in CV risk factors may be of lower magnitude, since other factors such as hormonal 307 
changes related to puberty may also influence lipid and insulin levels.37, 38 The comparison of changes 308 
in the specific periods evaluated here with other studies is difficult due to the differences in the 309 
periods evaluated, but two studies using data from the 1958 British birth cohort, and evaluating 310 
similar periods (11-16 years and 16-23 years) also found stronger associations for the changes in BMI 311 
from 16 to 23 years with adult glycosylated hemoglobin24 and blood pressure at 45 years.39 However, 312 
this could be because the period is closer in time to the outcome, rather than an effect of this 313 
specific period (17-21 years) under study, as described in other studies.22-24, 39 314 
 315 
In conclusion, our study identified three distinct trajectories of BMI and WC from adolescence to 316 
adulthood, and showed a benefit on the cardiovascular risk profile for those in the declining adiposity 317 
trajectory. The similar results for the two adiposity measures, support that both BMI and WC are 318 
surrogates of global adiposity. In addition, increases in BMI and WC, particularly recent changes from 319 
late adolescence-to-young adulthood, had a strong positive association with traditional 320 
cardiovascular risk factors. Our results highlight the importance of promote a healthy BMI at all ages 321 
to prevent unfavourable cardiovascular risk factors and future disease. 322 
 323 
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Supplementary information is available at International Journal of Obesity’s website.  324 
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Figure legends 444 
 445 
Figure 1. Trajectories of body mass index from 13 to 21 years of age in females (left) and in males 446 
(right), in the EPITeen cohort, Porto, Portugal 447 
 448 
Figure 2. Trajectories of waist circumference from 13 to 21 years of age in females (left) and in males 449 
(right), in the EPITeen cohort, Porto, Portugal 450 
